(Q35548548)

8 August 2017

1 reference

title

Alpha-synuclein oligomerization: a role for lipids? (English)

1 reference

8 August 2017

α-Synuclein oligomerization: a role for lipids? (English)

1 reference

https://api.crossref.org/works/10.1016/J.TINS.2003.08.001

17 March 2024

1 reference

Kevin Welch

1

1 reference

8 August 2017

Junying Yuan

2

1 reference

8 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14522142

17 March 2024

publication date

1 October 2003

1 reference

full work available at URL

8 August 2017

https://api.elsevier.com/content/article/PII:S0166223603002546?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.TINS.2003.08.001

https://api.elsevier.com/content/article/PII:S0166223603002546?httpAccept=text/plain

17 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.TINS.2003.08.001

17 March 2024

published in

Trends in Neurosciences

1 reference

8 August 2017

volume

26

1 reference

8 August 2017

issue

10

1 reference

8 August 2017

page(s)

517-519

1 reference

Alpha-synuclein and neurodegenerative diseases

8 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.TINS.2003.08.001

PAN, the proteasome-activating nucleotidase from archaebacteria, is a protein-unfolding molecular chaperone

17 March 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.TINS.2003.08.001

Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis

17 March 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.TINS.2003.08.001

Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases

17 March 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.TINS.2003.08.001

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

17 March 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.TINS.2003.08.001

Neurodegenerative disease: amyloid pores from pathogenic mutations.

17 March 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.TINS.2003.08.001

Vesicle permeabilization by protofibrillar alpha-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism.

17 March 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.TINS.2003.08.001

Golgi fragmentation occurs in the cells with prefibrillar alpha-synuclein aggregates and precedes the formation of fibrillar inclusion

17 March 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.TINS.2003.08.001

Dityrosine cross-linking promotes formation of stable alpha -synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies

17 March 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.TINS.2003.08.001

Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct

17 March 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.TINS.2003.08.001

Nitration inhibits fibrillation of human α‐synuclein in vitro by formation of soluble oligomers

17 March 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.TINS.2003.08.001

Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes

17 March 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.TINS.2003.08.001

alpha-Synuclein occurs in lipid-rich high molecular weight complexes, binds fatty acids, and shows homology to the fatty acid-binding proteins

17 March 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.TINS.2003.08.001

The formation of highly soluble oligomers of alpha-synuclein is regulated by fatty acids and enhanced in Parkinson's disease

17 March 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.TINS.2003.08.001

Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes

17 March 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.TINS.2003.08.001

Widespread alterations of alpha-synuclein in multiple system atrophy

17 March 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.TINS.2003.08.001

A radiochemical procedure for the assay of fatty acid binding by proteins

17 March 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.TINS.2003.08.001

Exposure to long chain polyunsaturated fatty acids triggers rapid multimerization of synucleins.

17 March 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.TINS.2003.08.001

Mice expressing the alpha(1B)-adrenergic receptor induces a synucleinopathy with excessive tyrosine nitration but decreased phosphorylation

17 March 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.TINS.2003.08.001

Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease

17 March 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.TINS.2003.08.001

17 March 2024

Identifiers

1 reference

8 August 2017

1 reference